Creo Medical Group PLC reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was GBP 30.8 million compared to GBP 27.2 million a year ago. Net loss was GBP 21.7 million compared to GBP 26.9 million a year ago.

Basic loss per share from continuing operations was GBP 0.07 compared to GBP 0.15 a year ago. Diluted loss per share from continuing operations was GBP 0.07 compared to GBP 0.15 a year ago.